Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honglin Tang

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Pharmacology and Experimental Therapeutics|December 29, 2018
Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung CancerHonglin Tang, Yanzhuo Liu, Chenlong Wang, et al.
Mucosal Immunology|February 14, 2019
Modulation of intestinal microbiota by glycyrrhizic acid prevents high-fat diet-enhanced pre-metastatic niche formation and metastasisMiao Qiu, Keqing Huang, Yanzhuo Liu, et al.
Acta Biomaterialia|January 29, 2023
A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapyYuan Chen, Zhuo Yao, Peilian Liu, et al.
Acta Pharmaceutica Sinica. B|August 15, 2022
Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinomaHonglin Tang, Yanan Xue, Bowen Li, et al.
Acta Biomaterialia|June 5, 2024
A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapyXin Xie, Zhiyao Li, Honglin Tang, et al.
Cancer Research|August 25, 2022
CYP4F2-Catalyzed Metabolism of Arachidonic Acid Promotes Stromal Cell-Mediated Immunosuppression in Non-Small Cell Lung CancerXuehan Chen, Yanzhuo Liu, Yang Wang, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Pharmacology and Experimental Therapeutics|December 29, 2018
Inhibition of COX-2 and EGFR by Melafolone Improves Anti-PD-1 Therapy through Vascular Normalization and PD-L1 Downregulation in Lung CancerHonglin Tang, Yanzhuo Liu, Chenlong Wang, et al.
Mucosal Immunology|February 14, 2019
Modulation of intestinal microbiota by glycyrrhizic acid prevents high-fat diet-enhanced pre-metastatic niche formation and metastasisMiao Qiu, Keqing Huang, Yanzhuo Liu, et al.
Acta Biomaterialia|January 29, 2023
A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapyYuan Chen, Zhuo Yao, Peilian Liu, et al.
Acta Pharmaceutica Sinica. B|August 15, 2022
Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinomaHonglin Tang, Yanan Xue, Bowen Li, et al.
Acta Biomaterialia|June 5, 2024
A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapyXin Xie, Zhiyao Li, Honglin Tang, et al.
Cancer Research|August 25, 2022
CYP4F2-Catalyzed Metabolism of Arachidonic Acid Promotes Stromal Cell-Mediated Immunosuppression in Non-Small Cell Lung CancerXuehan Chen, Yanzhuo Liu, Yang Wang, et al.
Pageof 3